FI80700C - Foerfarande foer framstaellning av terapeutiskt anvaendbara mitomycinanaloger. - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara mitomycinanaloger. Download PDF

Info

Publication number
FI80700C
FI80700C FI853338A FI853338A FI80700C FI 80700 C FI80700 C FI 80700C FI 853338 A FI853338 A FI 853338A FI 853338 A FI853338 A FI 853338A FI 80700 C FI80700 C FI 80700C
Authority
FI
Finland
Prior art keywords
formula
equivalent
mitomycin
compound
reaction
Prior art date
Application number
FI853338A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI80700B (fi
FI853338A0 (fi
FI853338L (fi
Inventor
Terrence William Doyle
Dolatrai Mohanlal Vyas
Richard A Partyka
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of FI853338A0 publication Critical patent/FI853338A0/fi
Publication of FI853338L publication Critical patent/FI853338L/fi
Priority to FI885222A priority Critical patent/FI89488C/fi
Publication of FI80700B publication Critical patent/FI80700B/fi
Application granted granted Critical
Publication of FI80700C publication Critical patent/FI80700C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI853338A 1984-09-04 1985-08-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara mitomycinanaloger. FI80700C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI885222A FI89488C (fi) 1984-09-04 1988-11-11 Nytt foerfarande foer framstaellning av 7-alkoxi-9a-metoximitosanderivat

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64688884A 1984-09-04 1984-09-04
US64688884 1984-09-04
US74457085A 1985-06-17 1985-06-17
US74457085 1985-06-17

Publications (4)

Publication Number Publication Date
FI853338A0 FI853338A0 (fi) 1985-08-30
FI853338L FI853338L (fi) 1986-03-05
FI80700B FI80700B (fi) 1990-03-30
FI80700C true FI80700C (fi) 1990-07-10

Family

ID=27095036

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853338A FI80700C (fi) 1984-09-04 1985-08-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara mitomycinanaloger.

Country Status (24)

Country Link
JP (1) JPS61112078A (el)
KR (2) KR900008570B1 (el)
AT (1) AT394723B (el)
AU (1) AU581673B2 (el)
BE (1) BE903169A (el)
CA (2) CA1291293C (el)
CH (2) CH667094A5 (el)
CY (2) CY1586A (el)
DE (1) DE3531453C2 (el)
DK (1) DK169478B1 (el)
ES (3) ES8702408A1 (el)
FI (1) FI80700C (el)
FR (1) FR2569696B1 (el)
GB (2) GB2164038B (el)
GR (1) GR852118B (el)
HK (2) HK22491A (el)
HU (1) HU195658B (el)
IE (1) IE58720B1 (el)
IT (1) IT1209660B (el)
LU (1) LU86062A1 (el)
NL (1) NL8502383A (el)
NO (1) NO169441C (el)
PT (1) PT81083B (el)
SE (2) SE465929B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803212A (en) * 1983-04-11 1989-02-07 Bristol-Myers Company Amino disulfides
US4888341A (en) * 1984-09-04 1989-12-19 University Patents, Inc. 6-substituted mitomycin analogs
IL86665A0 (en) * 1987-06-12 1988-11-30 Bristol Myers Co Mitomycin analogs
ZA886812B (en) * 1987-11-23 1989-07-26 Bristol Myers Co Anti-tumor prodrugs
US5023253A (en) * 1987-12-21 1991-06-11 University Patents, Inc. 6-substituted mitomycin analogs
US5175303A (en) * 1990-03-08 1992-12-29 Bristol-Myers Squibb Company Preparation of 7-(diphenylmethyl)oxy-9A-methoxymitosane
US5075454A (en) * 1990-03-08 1991-12-24 Bristol-Myers Squibb Company 7-(diphenylmethyl)oxy-9a-methoxymitosane

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3306821A (en) * 1962-09-04 1967-02-28 Upjohn Co Porfiromycin derivatives and method of making same
US4487769A (en) * 1982-06-04 1984-12-11 Bristol-Myers Company Amidines
JPS59175493A (ja) * 1983-03-25 1984-10-04 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体
DE3376114D1 (en) * 1982-12-07 1988-05-05 Kyowa Hakko Kogyo Kk Mitomycin analogues
US4803212A (en) * 1983-04-11 1989-02-07 Bristol-Myers Company Amino disulfides
KR840008362A (ko) * 1983-04-11 1984-12-14 사무엘 제이. 두보프 아미노 이황산염
US4888341A (en) * 1984-09-04 1989-12-19 University Patents, Inc. 6-substituted mitomycin analogs

Also Published As

Publication number Publication date
CH667457A5 (de) 1988-10-14
FR2569696B1 (fr) 1991-12-20
ES8702408A1 (es) 1986-12-16
FR2569696A1 (fr) 1986-03-07
SE9004157L (sv) 1992-06-28
HK22391A (en) 1991-04-04
FI80700B (fi) 1990-03-30
CA1254892A (en) 1989-05-30
HK22491A (en) 1991-04-04
NO169441B (no) 1992-03-16
CY1585A (en) 1992-04-03
AU581673B2 (en) 1989-03-02
ES553548A0 (es) 1987-06-16
IT1209660B (it) 1989-08-30
IT8522059A0 (it) 1985-09-03
HU195658B (en) 1988-06-28
CY1586A (en) 1992-04-03
GB2196006A (en) 1988-04-20
SE9004157D0 (sv) 1990-12-27
NL8502383A (nl) 1986-04-01
NO853435L (no) 1986-03-05
FI853338A0 (fi) 1985-08-30
ES8706326A1 (es) 1987-06-16
IE852174L (en) 1986-03-04
BE903169A (fr) 1986-03-03
DK401385A (da) 1986-03-05
GB8521816D0 (en) 1985-10-09
SE8504093D0 (sv) 1985-09-03
SE465929B (sv) 1991-11-18
IE58720B1 (en) 1993-11-03
LU86062A1 (fr) 1986-03-03
CH667094A5 (de) 1988-09-15
DE3531453A1 (de) 1986-03-13
ES546687A0 (es) 1986-12-16
GB8726516D0 (en) 1987-12-16
PT81083B (pt) 1988-01-22
GB2164038A (en) 1986-03-12
AT394723B (de) 1992-06-10
AU4571685A (en) 1986-03-13
ES8706327A1 (es) 1987-06-16
CA1291293C (en) 1991-10-22
GR852118B (el) 1986-01-07
ES553549A0 (es) 1987-06-16
KR900008570B1 (ko) 1990-11-24
NO169441C (no) 1992-06-24
GB2164038B (en) 1988-11-09
PT81083A (en) 1985-10-01
DE3531453C2 (de) 1996-07-18
GB2196006B (en) 1988-11-09
DK169478B1 (da) 1994-11-07
KR900008840B1 (ko) 1990-11-30
FI853338L (fi) 1986-03-05
HUT38942A (en) 1986-07-28
KR860002507A (ko) 1986-04-26
JPH0560469B2 (el) 1993-09-02
ATA258985A (de) 1991-11-15
DK401385D0 (da) 1985-09-03
JPS61112078A (ja) 1986-05-30
SE8504093L (sv) 1986-03-05

Similar Documents

Publication Publication Date Title
CN115175908A (zh) 芳基或杂芳基并吡啶酮或嘧啶酮类衍生物及其制备方法和应用
KR101982951B1 (ko) 신규한 유형의 시티딘 유도체 및 그의 용도
KR940006629B1 (ko) 아미노 디설파이드 티올 교환생성물의 제조방법
CN110683975B (zh) 一种二烷基氨基二硫代甲酸烷酯的合成方法
WO2006044402A1 (en) Furazano `3, 4-b ! pyrazynes and their use as anti-tumor agents
FI80700C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara mitomycinanaloger.
RU2129546C1 (ru) 6,9-бис(аминозамещенные)-бензо(g)изохинолин-5,10-дионы, способ их получения, фармацевтическая композиция на их основе и способ ингибирования опухолей у млекопитающих
PL171644B1 (en) Method of obtaining diastereoisomers of 1-(isopropoxycarbonyloxy)-ethyl 3-cephem-4-carboxylic ester
EP1610790B1 (en) Anticancer compounds
FI81099B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva mitomycinanaloger.
CH661273A5 (de) Mitomycinanaloge, welche eine disulfidgruppe enthalten.
FI79520B (fi) Foerfarande foer framstaellning av tioetrar.
US4814445A (en) Process for preparing mitomycin analogs
EP0390181B1 (en) Perylenequinone (UCN-1028D) derivatives
EP0329126B1 (en) Heterocyclic compounds and antiulcer agents
WO2022135591A1 (zh) 芳基或杂芳基并吡啶酮或嘧啶酮类衍生物及其制备方法和应用
US5258406A (en) Sulfonimidamides
US4927943A (en) Substituted 7-oxomitosanes
FI83085C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyridazo/1,2-a//1,2/diazepinderivat.
CZ154792A3 (en) Crystalline acid addition salts of diastereomerically pure 1-(2,2-dimethylpropionyloxy)-ethyl esters of 3-cephem-4-carboxylic acid
FI70026B (fi) Foerfarande foer framstaellning av 4-ureido-oxazafosforiner
JPH0555508B2 (el)
FI89488C (fi) Nytt foerfarande foer framstaellning av 7-alkoxi-9a-metoximitosanderivat
Hong et al. Synthesis and antitumor activity of 1-β-D-arabinofuranosylcytosine-5′-diphosphate-prednisolone and-cortisol
US5097036A (en) Substituted 7-oxomitosanes

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY